Skip to main content
Fig. 3 | EJNMMI Radiopharmacy and Chemistry

Fig. 3

From: Preclinical evaluation of an 18F-labeled Nε-acryloyllysine piperazide for covalent targeting of transglutaminase 2

Fig. 3

Metabolic stability and arterial blood clearance of [18F]7b in a normal Wistar rat. A Radio-HPLC chromatograms of [18F]7b in samples of blood and excretion media taken at different time points after i.v. injection of [18F]7b. B Time course of arterial blood clearance of intact [18F]7b as calculated from activity measurement of blood samples and fraction of intact [18F]7b determined by radio-HPLC and radio-TLC (Additional file 1: Fig. S3) including nonlinear regression according to two-phase decay. The inset shows the respective semi-logarithmic plot with separate linear regressions for the time points 1–3 min (dotted line, extrapolated up to the x-axis) and 3–30 min (solid line, extrapolated up to the y-axis). From the results of the latter linear regression, c02 and kel were derived (see Methods section). Data in A and B are from the same experiment, in which [18F]7b (69.8 MBq, 5.27 nmol) was injected into a healthy Wistar rat (body weight of 170 g)

Back to article page